The USFDA had inspected the plant from September 11, 2017 to September 15, 2017.
The company said it had submitted a detailed corrective and preventive action (CAPA) plan to the USFDA within the stipulated time lines in response to the two Form 483 observations issued by the regulator.
"The inspection has now been closed by the USFDA," it added.
USFDA releases a copy of the EIR to the establishment that is subject of an FDA or FDA-contracted inspection when the agency determines the same to be closed.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)